Asgpr-binding compounds for the degradation of extracellular proteins
US-2024424108-A1 · Dec 26, 2024 · US
US10351600B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10351600-B2 |
| Application number | US-201715663043-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 28, 2017 |
| Priority date | Apr 26, 2013 |
| Publication date | Jul 16, 2019 |
| Grant date | Jul 16, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A peptide that enables surface treatment of a scaffold for tissue repair that makes it possible to accelerate the repair of living tissue without using a material that negatively affects the repair of living tissue, a complex containing this peptide, a scaffold for tissue repair surface treated using this peptide or this complex, a surface treatment method for a scaffold for tissue repair using this peptide or this complex, and a treatment solution or set of treatment solutions to be used in this surface treatment method. Surface treatment of a scaffold for tissue repair is conducted by combining glycosaminoglycan and a peptide containing adhesive sites and basic sites each comprising predetermined amino acid residues.
Opening claim text (preview).
We claim: 1. A complex of peptide and glycosaminoglycan, wherein the peptide comprises, in the amino acid sequence thereof, an adhesive site consisting of residues of amino acids including a 2,3-dihydroxyphenyl group or 3,4-dihydroxyphenyl group, and a basic site including three or more consecutive basic amino acid residues; wherein the adhesive site and the basic site bind via a spacer site, and wherein the glycosaminoglycan is binding at the basic site. 2. The complex according to claim 1 , wherein a sequence of nine resides from the C terminus of the peptide is an amino acid sequence represented by SEQ ID NO 1. 3. A complex of the complex according to claim 1 and a cell growth factor, wherein the cell growth factor is binding with the glycosaminoglycan. 4. A scaffold for tissue repair, wherein the complex according to claim 1 is binding to the surface thereof at the adhesive site. 5. A scaffold for tissue repair, wherein a complex of the complex according to claim 1 and a cell growth factor are binding to a surface of the scaffold at the adhesive site. 6. A treatment solution for surface treatment of a scaffold for tissue repair, comprising the complex according to claim 1 . 7. A set of treatment solutions for surface treatment of a scaffold for tissue repair, comprising the treatment solution according to claim 6 and a treatment solution containing cell growth factor. 8. A treatment solution for surface treatment of a scaffold for tissue repair, comprising a complex of the complex according to claim 1 and a cell growth factor.
Fibroblast growth factor [FGF] · CPC title
Growth factors · CPC title
Phosphorus-containing materials, e.g. apatite · CPC title
Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof · CPC title
Peptides having up to 20 amino acids in a defined sequence · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.